• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用临床及超声特征对甲状腺乳头状癌滤泡变体中央淋巴结转移进行术前预测。

Preoperative prediction of central lymph node metastasis in follicular variant of papillary thyroid carcinoma using clinical and ultrasound features.

作者信息

Zheng Yuxin, Zhang Yajiao, Chen Liyu, Lu Kefeng, Liu Junping, Lou Jiangyan

机构信息

Second Clinical College, Zhejiang University of Traditional Chinese Medicine, Hangzhou, China.

Department of Diagnostic Ultrasound Imaging & Interventional Therapy, Zhejiang Cancer Hospital, Hangzhou, China.

出版信息

Gland Surg. 2024 Jun 30;13(6):812-824. doi: 10.21037/gs-23-492. Epub 2024 Jun 27.

DOI:10.21037/gs-23-492
PMID:39015704
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11247580/
Abstract

BACKGROUND

The most common metastatic site of follicular variant of papillary thyroid carcinoma (FVPTC) is the central lymph nodes, which may be associated with the prognosis and survival of patients. In the present study, we establish a combined model based on preoperative clinical and ultrasound (US) features of FVPTC to predict the risk of central lymph node metastasis (CLNM).

METHODS

From January 2013 to December 2022, 315 patients with FVPTC were enrolled and randomly divided into the training and validation cohorts in a ratio of 7:3. The independent risk factors for CLNM in FVPTC were analysed using univariate and multivariate logistic regression analyses. Then, three different models were established based on clinical and US data. Subsequently, a nomogram was constructed to predict CLNM. Its predictive effect was evaluated via receiver operating characteristic and calibration curve analyses.

RESULTS

Backward multivariate regression analysis revealed that age (P=0.001), thyroid peroxidase antibody (TPOAb) (P=0.11), diameter (P=0.047), irregular/lobulated margin (P=0.15), extrathyroidal extension (P=0.001), nodules with macrocalcifications (P=0.009), nodules with microcalcification (P=0.003) and Thyroid Imaging Reporting and Data System (ACR-TI-RADS) category 5 (P=0.33) were independent risk factors for CLNM in FVPTC. The areas under the curve of the matching nomogram in the training (N=221) and validation cohorts (N=94) were 0.841 [95% confidence interval (CI): 0.788-0.895] and 0.735 (95% CI: 0.621-0.872), respectively.

CONCLUSIONS

Preoperative thyroid US provides useful features for prediction of CLNM. The nomogram constructed based on combining US and clinical features can better predict the risk of CLNM and may facilitate decision-making in clinical settings.

摘要

背景

甲状腺乳头状癌滤泡变体(FVPTC)最常见的转移部位是中央淋巴结,这可能与患者的预后和生存相关。在本研究中,我们基于FVPTC的术前临床和超声(US)特征建立了一个联合模型,以预测中央淋巴结转移(CLNM)的风险。

方法

2013年1月至2022年12月,纳入315例FVPTC患者,并按7:3的比例随机分为训练队列和验证队列。采用单因素和多因素逻辑回归分析FVPTC中CLNM的独立危险因素。然后,基于临床和超声数据建立了三种不同的模型。随后,构建列线图以预测CLNM。通过受试者工作特征曲线和校准曲线分析评估其预测效果。

结果

向后多因素回归分析显示,年龄(P=0.001)、甲状腺过氧化物酶抗体(TPOAb)(P=0.11)、直径(P=0.047)、边缘不规则/分叶状(P=0.15)、甲状腺外侵犯(P=0.001)、有粗大钙化的结节(P=0.009)、有微钙化的结节(P=0.003)和美国放射学会甲状腺影像报告和数据系统(ACR-TI-RADS)5类(P=0.33)是FVPTC中CLNM的独立危险因素。训练队列(N=221)和验证队列(N=94)中匹配列线图的曲线下面积分别为0.841 [95%置信区间(CI):0.788-0.895]和0.735(95%CI:0.621-0.872)。

结论

术前甲状腺超声为预测CLNM提供了有用的特征。基于超声和临床特征相结合构建的列线图可以更好地预测CLNM的风险,并可能有助于临床决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d11/11247580/42dfdd89743b/gs-13-06-812-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d11/11247580/88aad8c80044/gs-13-06-812-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d11/11247580/b687913c29f1/gs-13-06-812-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d11/11247580/03424beb54c8/gs-13-06-812-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d11/11247580/66e1ac5458db/gs-13-06-812-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d11/11247580/42dfdd89743b/gs-13-06-812-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d11/11247580/88aad8c80044/gs-13-06-812-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d11/11247580/b687913c29f1/gs-13-06-812-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d11/11247580/03424beb54c8/gs-13-06-812-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d11/11247580/66e1ac5458db/gs-13-06-812-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d11/11247580/42dfdd89743b/gs-13-06-812-f5.jpg

相似文献

1
Preoperative prediction of central lymph node metastasis in follicular variant of papillary thyroid carcinoma using clinical and ultrasound features.利用临床及超声特征对甲状腺乳头状癌滤泡变体中央淋巴结转移进行术前预测。
Gland Surg. 2024 Jun 30;13(6):812-824. doi: 10.21037/gs-23-492. Epub 2024 Jun 27.
2
Predicting central lymph node metastasis in papillary thyroid cancer: A nomogram based on clinical, ultrasound and contrast‑enhanced computed tomography characteristics.预测甲状腺乳头状癌中央淋巴结转移:基于临床、超声及增强计算机断层扫描特征的列线图
Oncol Lett. 2024 Aug 5;28(4):478. doi: 10.3892/ol.2024.14611. eCollection 2024 Oct.
3
Nomogram for Preoperative Estimation of Cervical Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma.甲状腺微小乳头状癌颈淋巴结转移风险术前预测列线图
Front Endocrinol (Lausanne). 2021 Mar 31;12:613974. doi: 10.3389/fendo.2021.613974. eCollection 2021.
4
An integrated nomogram combining deep learning, clinical characteristics and ultrasound features for predicting central lymph node metastasis in papillary thyroid cancer: A multicenter study.基于深度学习、临床特征和超声特征的综合列线图预测甲状腺乳头状癌中央区淋巴结转移:一项多中心研究。
Front Endocrinol (Lausanne). 2023 Feb 21;14:964074. doi: 10.3389/fendo.2023.964074. eCollection 2023.
5
Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.基于术前血清甲状腺球蛋白和甲状腺乳头状癌临床特征的列线图模型预测颈部淋巴结转移。
Front Endocrinol (Lausanne). 2022 Jul 15;13:937049. doi: 10.3389/fendo.2022.937049. eCollection 2022.
6
Nomogram based on preoperative conventional ultrasound and shear wave velocity for predicting central lymph node metastasis in papillary thyroid carcinoma.基于术前常规超声和剪切波速度的列线图预测甲状腺乳头状癌中央区淋巴结转移
Clin Hemorheol Microcirc. 2023;83(2):129-136. doi: 10.3233/CH-221576.
7
Development and validation of a nomogram for preoperative prediction of ipsilateral cervical central lymph node metastasis in papillary thyroid cancer: a population-based study.甲状腺乳头状癌同侧颈中央区淋巴结转移术前预测列线图的开发与验证:一项基于人群的研究
Gland Surg. 2024 Apr 29;13(4):528-539. doi: 10.21037/gs-23-478. Epub 2024 Apr 22.
8
Papillary Thyroid Microcarcinoma: A Nomogram Based on Clinical and Ultrasound Features to Improve the Prediction of Lymph Node Metastases in the Central Compartment.甲状腺微小乳头状癌:基于临床和超声特征的列线图,以提高中央区淋巴结转移的预测准确性。
Front Endocrinol (Lausanne). 2022 Jan 12;12:770824. doi: 10.3389/fendo.2021.770824. eCollection 2021.
9
Preoperative prediction of central lymph node metastasis in cN0T1/T2 papillary thyroid carcinoma: A nomogram based on clinical and ultrasound characteristics.术前预测 cN0T1/T2 期甲状腺乳头状癌中央区淋巴结转移:基于临床和超声特征的列线图
Eur J Surg Oncol. 2022 Jun;48(6):1272-1279. doi: 10.1016/j.ejso.2022.04.001. Epub 2022 Apr 6.
10
The model for predicting the central lymph node metastasis in cN0 papillary thyroid microcarcinoma with Hashimoto's thyroiditis.预测伴有桥本甲状腺炎的 cN0 期甲状腺微小乳头状癌中央区淋巴结转移的模型。
Front Endocrinol (Lausanne). 2024 Apr 30;15:1330896. doi: 10.3389/fendo.2024.1330896. eCollection 2024.

本文引用的文献

1
2023 European Thyroid Association Clinical Practice Guidelines for thyroid nodule management.2023 年欧洲甲状腺协会甲状腺结节管理临床实践指南。
Eur Thyroid J. 2023 Aug 14;12(5). doi: 10.1530/ETJ-23-0067. Print 2023 Oct 1.
2
An integrated nomogram combining deep learning, clinical characteristics and ultrasound features for predicting central lymph node metastasis in papillary thyroid cancer: A multicenter study.基于深度学习、临床特征和超声特征的综合列线图预测甲状腺乳头状癌中央区淋巴结转移:一项多中心研究。
Front Endocrinol (Lausanne). 2023 Feb 21;14:964074. doi: 10.3389/fendo.2023.964074. eCollection 2023.
3
Diagnostic performance of six ultrasound-based risk stratification systems in thyroid follicular neoplasm: A retrospective multi-center study.
六种基于超声的甲状腺滤泡性肿瘤风险分层系统的诊断性能:一项回顾性多中心研究。
Front Oncol. 2022 Oct 20;12:1013410. doi: 10.3389/fonc.2022.1013410. eCollection 2022.
4
Risk factors and prediction models of lymph node metastasis in papillary thyroid carcinoma based on clinical and imaging characteristics.基于临床和影像特征的甲状腺乳头状癌淋巴结转移的危险因素及预测模型
Postgrad Med. 2023 Mar;135(2):121-127. doi: 10.1080/00325481.2022.2135840. Epub 2022 Oct 18.
5
Central Compartment Lymph Nodes Have Distinct Metastatic Patterns in Different Age Groups.中央隔室淋巴结在不同年龄组中有不同的转移模式。
Front Endocrinol (Lausanne). 2022 Feb 17;13:807431. doi: 10.3389/fendo.2022.807431. eCollection 2022.
6
Lymph node metastasis of papillary thyroid carcinoma in the context of Hashimoto's thyroiditis.桥本甲状腺炎背景下甲状腺乳头状癌的淋巴结转移。
BMC Endocr Disord. 2022 Jan 5;22(1):12. doi: 10.1186/s12902-021-00923-2.
7
Performance of current ultrasound-based malignancy risk stratification systems for thyroid nodules in patients with follicular neoplasms.基于超声的甲状腺滤泡肿瘤结节恶性风险分层系统在甲状腺结节患者中的应用效能。
Eur Radiol. 2022 Jun;32(6):3617-3630. doi: 10.1007/s00330-021-08450-3. Epub 2022 Jan 1.
8
Nomogram to Assess the Risk of Central Cervical Lymph Node Metastasis in Patients With Clinical N0 Papillary Thyroid Carcinoma.评估临床 N0 期甲状腺乳头状癌患者中央颈部淋巴结转移风险的列线图。
Endocr Pract. 2021 Dec;27(12):1175-1182. doi: 10.1016/j.eprac.2021.06.010. Epub 2021 Jun 24.
9
A Nomogram Based on Clinical and Ultrasound Characteristics to Predict Central Lymph Node Metastasis of Papillary Thyroid Carcinoma.基于临床和超声特征的列线图预测甲状腺乳头状癌中央区淋巴结转移。
Front Endocrinol (Lausanne). 2021 Apr 28;12:666315. doi: 10.3389/fendo.2021.666315. eCollection 2021.
10
Risk factors for central lymph node metastasis in the cervical region in papillary thyroid carcinoma: a retrospective study.甲状腺乳头状癌颈部中央淋巴结转移的危险因素:一项回顾性研究
World J Surg Oncol. 2021 Apr 30;19(1):138. doi: 10.1186/s12957-021-02247-w.